Laparoscopic Resection of a Virilizing Adrenocortical Tumor by Castellano, Joseph J. et al.
Laparoscopic Resection of a
Virilizing Adrenocortical Tumor
Joseph J. Castellano, MD, Matthew W. Warren, PhD, May R. Arroyo, MD, Juan C. Cendan, MD
ABSTRACT
Virilizing adrenocortical tumors are rare. Laparoscopic
unilateral adrenalectomy with serum androgen surveil-
lance may provide curative treatment for benign, func-
tional adenomas. Herein, we describe a case of laparo-
scopic resection of a testosterone-producing adrenal
tumor in a sixteen-year-old female.
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INTRODUCTION
Adrenocortical tumors (ACTs) are rare in the pediatric
population and make up only 0.2% of childhood cancers.1
Virilizing tumors are neoplasms that secrete androgens
and manifest clinically as masculinization in females.
Common signs and symptoms include hirsutism, acne,
increased muscle mass, amenorrhea, and clitoromegaly.
Such tumors arising in the adrenal cortex are rare, but
virtually all cases are symptomatic.2 The differential diag-
nosis includes tumors of the gonads and pituitary as well
as polycystic ovarian syndrome, congenital adrenal hyper-
plasia, and exogenous steroid exposure. The workup in-
volves measurement of glucocorticoids and androgens, a
dexamethasone suppression test, and abdominal com-
puted tomography (CT) scanning.
Surgical unilateral adrenalectomy is curative in neoplasms
that have not locally invaded or metastasized. Tradition-
ally, there have been 4 distinct approaches the surgeon
can choose from. The open approaches are anterior trans-
abdominal, thoracoabdominal, flank/retroperitoneal, and
posterior. Secondary to the advances in laparoscopic in-
strumentation and techniques, there has been a progres-
sion towards laparoscopic adrenalectomy, either by a
transabdominal approach or retroperitoneal approach.
We report one case of a virilizing ACT in a 16-year-old
female that was excised laparoscopically.
CASE REPORT
A 16-year-old, competitive, high school female athlete
was seen with symptoms of virilization. The patient re-
ported several years of vague fatigue and in the last year
hirsutism. This had been associated with secondary am-
enorrhea. The patient’s menses began approximately at
age 11 to 12, but she then developed long intervals be-
tween menstrual cycles. Her other developmental mile-
stones had been normal. The patient’s past medical
history was unremarkable otherwise. On physical exami-
nation, the head and neck revealed evidence of hirsutism
and acne. The patient had been shaving along the lateral
face and the under surface of her chin and slightly over
the upper lip area. She had well-defined musculature
increases in her upper and lower extremities but within
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CASE REPORTnormal parameters of appearance for a female. She had a
normal-sounding voice that was not deep. Her abdomen
was soft and flat. There was no palpable abdominal mass.
She was Tanner stage V for pubic hair and IV for breasts,
with evidence of clitoromegaly.
The patient had a thorough workup that included cortisol,
estradiol, testosterone, dehydroepiandrosterone (DHEAS),
and progesterone testing, all of which were normal with the
exception of the testosterone level that was 1558 pg/mL, 20
to 40 times normal levels. The DHEAS in her saliva was also
4 times normal. All of these pointed to a testosterone-secret-
ing tumor. These testing results led to a CT of the abdomen
to evaluate for abnormalities of the adrenal glands, and a
large left adrenal mass was identified (Figure 1). The lesion
was approximately 8 cm in its largest diameter. The right
adrenal gland appeared normal. The remainder of the ab-
dominal CT was normal.
A decision was made to remove the left adrenal gland
laparoscopically. The splenic reflection was then taken all
the way up to the gastroesophageal junction allowing the
spleen and tail of the pancreas to fall forward and the
tumor to be seen. The tumor mass was a deep red color
and superficially covered with prominent vessels. It was
relatively smooth in its appearance and there were areas
of speckled yellow consistent with the adrenal origin.
Along its medial and inferior aspect, there seemed to be a
tongue of normal adrenal gland that was compressed
inferiorly. The separation between the kidney and the
mass could be initially seen without dissection. The dis-
section was then completed, and the gland was freed from
the retroperitoneum. A specimen bag was used for re-
moval through the camera trocar site. This site was then
expanded to accommodate passage of the gland that hap-
pened at approximately 4 cm in dimension.
The pathologic specimen consisted of a 138 g adrenalec-
tomy measuring 9.5x6.0x3.5 cm. A cut section revealed a
well-circumscribed, red-brown tumor with focal hemor-
rhagic areas (Figure 2A). A thin ribbon of residual adrenal
gland was present. The tumor cells contained abundant
eosinophilic cytoplasm and small central nuclei with in-
conspicuous nucleoli (Figure 2B). No mitoses were seen
in 30 examined high-power fields. No necrosis, severe
nuclear atypia, vascular invasion, or invasion into periad-
renal soft tissue was identified.
The patient was discharged on postoperative day 2. Lab-
oratory values on that day showed a normal cortisol and a
normal serum testosterone level of less than 20 ng/dL.
Follow-up will include monitoring adrenal androgens to
document chemical evidence of remission, including
DHEAS, testosterone, estradiol, and cortisol. Annual CT
will be obtained to evaluate the retroperitoneum for re-
currence.
DISCUSSION
Virilizing ACTs are extremely rare. The differential diag-
nosis of hyperandrogenism includes exogenous use of
anabolic steroids, adrenal causes, and extra-adrenal
causes. The adrenal causes are congenital adrenal hyper-
plasia, adrenocortical adenoma (ACA), adrenocortical car-
cinoma (ACC), and exaggerated adrenarche. The extra-
adrenal causes are polycystic ovary, adrenal rests, ovarian
tumors, testicular tumors, adrenal hyperplasia secondary
to a pituitary adenoma or ectopic secretion of ACTH or
CRH, hyperprolactinemia, and acromegaly.
ACTs are reported to occur in infancy through childhood,
with a reported incidence of 0.3 per million. Fifty percent
to 80% of these tumors lead to virilization alone, and 20%
to 40% occur with Cushing’s syndrome.3
Distinguishing between a benign and malignant ACT can
be difficult, even with pathology. The best determination
of malignancy is the clinical course. Prognostic indicators,
such as tumor size, weight, and histological grade, have
yet to have their significance studied substantially. Addi-
tionally, there are no good histologic criteria for distin-
guishing adenoma from carcinoma. A recent study of
adrenal cortical neoplasms in the pediatric population
reported an increased probability of malignant clinical
behavior with tumor weight greater than 400 g, tumor size
greater than 10.5 cm, vena cava invasion, capsular inva-
Figure 1. Abdominal computed tomography showing an 8-cm
left adrenal lesion (borders marked with arrows).
Laparoscopic Resection of a Virilizing Adrenocortical Tumor, Castellano JJ et al.
JSLS (2008)12:343–346 344sion, vascular invasion, confluent necrosis, severe nuclear
atypia, increased mitotic rate, and the presence of atypical
mitoses.4
Whether an ACT is hormonally silent (nonfunctional) or
hormone secreting (functional) does not predict sur-
vival. Rather the stage, localized, regional, or meta-
static, of the ACT is a better indicator of survival. A
positive correlation has been shown between clinical
stage and urinary levels of steroid metabolites. Viriliza-
tion is the most common presentation, followed by
Cushing’s syndrome.3,5,6 Benign ACTs were less likely
to present with Cushing’s syndrome. The most common
sites of metastases are the lung and liver. Metastases
should be resected if possible.5
The operative technique used depends on the associated
disease, the overall health of the patient, bilaterality, and
the surgeon’s experience with each procedure. The pos-
terior and flank/retroperitoneal approach offer the advan-
tage of not entering the peritoneal cavity. This leads to less
postoperative pain, ileus, and respiratory insufficiency.7,8
This is best suited for benign, small to moderate sized
masses. The anterior/transabdominal approach offers ex-
cellent exposure and is the preferred method for large or
malignant tumors.9 All major visceral vascular structures
that are potentially involved can be accessed through this
approach. In rare cases, the thoracoabdominal approach
may be necessary in the case of giant malignant lesions
when extensive exposure is needed.9 This approach has a
high potential for morbidity. Laparoscopic adrenalectomy
offers 2 techniques, the transabdominal and retroperito-
neal. Compared with the open procedure, many studies
have shown a postoperative hospital stay of 2 to 3 days,
decreased blood loss, and decreased need for narcotics in
the laparoscopic group.10–13 The transabdominal ap-
proach has the advantages of a large working space,
anatomic landmarks, and overall success.14 The retroper-
itoneal approach has the advantage of not entering the
peritoneal cavity, no need to retract organs, and a likely
decrease in postoperative ileus.11,15 On the other hand,
this approach offers a smaller working space, fewer land-
marks, and is usually restricted to tumors smaller than 5
cm. The main contraindication to laparoscopic surgery is
suspected malignancy.9 We used a laparoscopic transab-
dominal approach, which was necessary secondary to the
size of this tumor. The laparoscopic approach of tumors
larger than 6 cm has been shown to be safe.16 We ap-
proach all ACT cases laparoscopically through a transab-
dominal approach, unless they are 12 cm to 15 cm, or
evidence is clear cut that local organ invasion has oc-
curred. We will also approach some small cancers lapa-
roscopically.
In this case, pathologic criteria were not met for a carci-
noma classification. In fact, the rapid normalization of
serum testosterone levels within 48 hours suggests, but
does not prove, a curative laparoscopic excision of an
adenoma as seen in previous cases.17 In addition to short-
term follow-up for resolution of the masculinizing signs
and symptoms, we suggest annual testosterone screening
for 5 years.
Figure 2. Adrenocortical tumor microscopic aspects: A. Adrenocortical neoplasm with compressed adrenal cortex (left portion of field);
B. Tumor cells have abundant eosinophilic cytoplasm and small round nuclei (hematoxylin & eosin).
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Testosterone-producing adrenocortical tumors are rare.
Laparoscopic unilateral adrenalectomy with measurement
of serum androgens provides a feasible and effective
method of treatment.
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